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Although echocardiography is the most popular noninva-
sive test to assess cardiac risk before noncardiac surgery (NCS), 
the guideline
1) recommends that resting echocardiography is 
useful in selected cases such as patients with dyspnea of un-
known origin or those with congestive heart failure. In fact, 
there are distinct gaps in echocardiography use between real 
practice and the current guideline. A study by Park et al.
2) test-
ed whether resting echocardiography is useful to predict car-
diac complications in patients undergoing NCS. They evalu-
ated resting transthoracic echocardiography together with 
clinical risk factors and N-terminal pro-brain type natriuretic 
peptide (NT-proBNP) levels in 1,923 patients. Three echo-
cardiographic parameters {left ventricular ejection fraction 
(LVEF), regional wall motion score index, and E/E’} were 
inferior to NT-proBNP level and not better than clinical risk 
factors.
3) Thus, the authors suggested that routine echocar-
diography is not helpful to predict major cardiac events.
Perioperative cardiac risk can be assessed by clinical risk in-
dices, noninvasive cardiac tests, and invasive cardiac tests. 
Echocardiography provides information on LVEF, diastolic 
function, and regional wall motion abnormalities. However, 
the study by Halm et al.
4) demonstrated that LVEF has low 
sensitivity (29%) to predict cardiac outcomes and could not 
predict congestive heart failure before NCS. Thus, resting LV-
EF has been ascribed limited prognostic value. The current 
guideline
1) does not recommend a routine evaluation of rest-
ing LV function. Echocardiographic studies related to NCS 
mainly include stress echocardiography. Stress echocardiog-
raphy can detect ischemia, which is an important factor for 
postoperative cardiac events. Furthermore, stress echocardio-
graphy is superior to thallium imaging to predict postopera-
tive cardiac events.
5) Comparing resting echocardiography 
with NT-proBNP level to predict postoperative cardiac events 
in patients undergoing NCS is somewhat unfair, because el-
evated NT-proBNP level is related not only to ischemic bur-
den but also to impaired cardiac function. As expected, NT-
proBNP level is superior to LVEF or E/E’ for predicting car-
diac events. It has been known that LVEF is a weak indicator 
for congestive heart failure (CHF), because it does not repre-
sent diastolic heart failure, and reduced LVEF does not always 
provoke CHF. In contrast, E/E’ is an accurate echocardio-
graphic index for detecting CHF regardless of LVEF. More-
over, E/E’ is more accurate than BNP level to diagnose CHF 
with reduced LVEF.
6) However, in the study by Part et al.
2) E/E’ 
has weaker power for predicting CHF or overall cardiac ev-
ents than that of NT-proBNP level. These results suggest that 
the comparative accuracy of E/E’ and BNP differs according 
to CHF severity. Namely, E/E’ is more accurate in sicker pa-
tients, whereas BNP level is more helpful in healthy patients. 
In the present issue.
2) Almost 95% of patients have normal 
or mildly depressed LVEF, which is an important limitation 
when comparing BNP levels and echocardiography. More 
reliable results of the predictive value of the two modalities 
would warrant studies on selected patient groups. Further-
more, a comparison of stress echocardiography and BNP le-
vel would be more interesting. 
The importance of the present study lies in that it is the first 
to compare predictive power between a biomarker and echo-
cardiography in a large number of subjects. The message from 
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this study is that NT-proBNP level is more accurate than echo-
cardiography to predict future major cardiac events in non-
high risk patients undergoing NCS. Therefore, BNP level can 
be used for risk assessment before surgery without echocar-
diography in the near future. Although resting echocardiog-
raphy has weak predictive power for cardiac risk during NCS, 
it has additional advantages. Many physicians order preop-
erative echocardiography for reasons other than predicting 
cardiac risk, for example, to assess valvular disease and to ob-
tain information that can guide medication prescriptions (e.g., 
angiotensin-converting enzyme inhibitors) in patients with 
reduced LVEF. 
In conclusion, the study by Park et al.
2) demonstrates that 
preoperative echocardiography compared with clinical risk 
factors and NT-proBNP level has limited value for predict-
ing major cardiovascular events.
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